Marinus Pharmaceuticals, Inc.
MRNS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$141 | -$20 | -$99 | -$67 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | -$1 | $0 |
| Stock-Based Comp. | $16 | $15 | $14 | $8 |
| Change in WC | $2 | -$6 | $29 | -$2 |
| Other Non-Cash | $5 | -$102 | $1 | $1 |
| Operating Cash Flow | -$118 | -$113 | -$55 | -$61 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$3 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$52 | -$0 | $0 | -$9 |
| Inv. Sales/Matur. | $24 | $107 | $1 | $8 |
| Other Inv. Act. | $0 | $0 | $1 | -$1 |
| Investing Cash Flow | -$29 | $106 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $59 | $40 | $0 |
| Stock Issued | $26 | $64 | $1 | $108 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $2 | $1 | $1 |
| Financing Cash Flow | $27 | $125 | $41 | $109 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$120 | $118 | -$16 | $48 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $241 | $123 | $139 | $91 |
| End Cash | $121 | $241 | $123 | $139 |
| Free Cash Flow | -$118 | -$115 | -$58 | -$61 |